AU569294B2 - Antibiotic bbm-1675a and b, from actinomadura verrucosospora - Google Patents

Antibiotic bbm-1675a and b, from actinomadura verrucosospora

Info

Publication number
AU569294B2
AU569294B2 AU27791/84A AU2779184A AU569294B2 AU 569294 B2 AU569294 B2 AU 569294B2 AU 27791/84 A AU27791/84 A AU 27791/84A AU 2779184 A AU2779184 A AU 2779184A AU 569294 B2 AU569294 B2 AU 569294B2
Authority
AU
Australia
Prior art keywords
actinomadura verrucosospora
antibiotic bbm
bbm
antibiotic
verrucosospora
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU27791/84A
Other languages
English (en)
Other versions
AU2779184A (en
Inventor
Hiroshi Kawaguchi
Masataka Konishi
Hiroaki Ohkuma
Kyoichiro Saitoh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of AU2779184A publication Critical patent/AU2779184A/en
Application granted granted Critical
Publication of AU569294B2 publication Critical patent/AU569294B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/02—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using fungi
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/08—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals directly attached to carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU27791/84A 1983-05-16 1984-05-08 Antibiotic bbm-1675a and b, from actinomadura verrucosospora Ceased AU569294B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49523183A 1983-05-16 1983-05-16
US495231 2000-01-31

Publications (2)

Publication Number Publication Date
AU2779184A AU2779184A (en) 1984-11-22
AU569294B2 true AU569294B2 (en) 1988-01-28

Family

ID=23967812

Family Applications (1)

Application Number Title Priority Date Filing Date
AU27791/84A Ceased AU569294B2 (en) 1983-05-16 1984-05-08 Antibiotic bbm-1675a and b, from actinomadura verrucosospora

Country Status (28)

Country Link
JP (2) JPS59232094A (fr)
KR (2) KR840008817A (fr)
AT (1) AT393691B (fr)
AU (1) AU569294B2 (fr)
BE (1) BE899667A (fr)
CA (1) CA1241282A (fr)
CY (1) CY1465A (fr)
DE (1) DE3418023A1 (fr)
DK (1) DK163127C (fr)
ES (1) ES8700267A1 (fr)
FI (1) FI81114C (fr)
FR (1) FR2547594B1 (fr)
GB (1) GB2141425B (fr)
GR (1) GR81581B (fr)
HK (1) HK9889A (fr)
HU (1) HU193928B (fr)
IE (1) IE57444B1 (fr)
IL (1) IL71824A (fr)
IT (1) IT1175498B (fr)
KE (1) KE3846A (fr)
LU (1) LU85362A1 (fr)
NL (1) NL8401572A (fr)
NZ (1) NZ208013A (fr)
PT (1) PT78590A (fr)
SE (1) SE460364B (fr)
SU (1) SU1344249A3 (fr)
YU (1) YU43846B (fr)
ZA (1) ZA843591B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR78648B (fr) * 1982-07-26 1984-09-27 Bristol Myers Co
IL79519A0 (en) * 1985-08-27 1986-10-31 Bristol Myers Co Bbm-1675c and d antitumor antibiotics
US4837206A (en) * 1987-04-29 1989-06-06 Bristol-Myers Company Esperamicin derivatives
US4996305A (en) * 1988-02-29 1991-02-26 American Cyanamid Company Process for producing the antibiotic and antitumor agents LL-E33288.epsilon.ε-Br
CA2027601A1 (fr) * 1989-11-06 1991-05-07 Koko Sugawara Antibiotique antitumeur bu-3983t
CN115380211A (zh) * 2021-03-17 2022-11-22 日本水产株式会社 精制的方法和经精制的产品

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1720083A (en) * 1982-07-26 1984-02-02 Bristol-Myers Company Protein antibiotic bbm-1644 from actinomadura sp h710-49 atcc 39144
AU4979085A (en) * 1984-11-13 1986-05-22 Warner-Lambert Company Cl-1577d, 1557e antibiotic/antitumor compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4195079A (en) * 1979-01-31 1980-03-25 Pfizer Inc. New polycyclic ether antibiotic
JPS56113791A (en) * 1980-02-15 1981-09-07 Kaken Pharmaceut Co Ltd Novel antibiotic and its preparation

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1720083A (en) * 1982-07-26 1984-02-02 Bristol-Myers Company Protein antibiotic bbm-1644 from actinomadura sp h710-49 atcc 39144
AU4979085A (en) * 1984-11-13 1986-05-22 Warner-Lambert Company Cl-1577d, 1557e antibiotic/antitumor compounds
AU4985885A (en) * 1984-11-13 1986-05-22 Warner-Lambert Company CL-1577D and 1577E antibiotic/antitumor compounds, their production and use

Also Published As

Publication number Publication date
HK9889A (en) 1989-02-10
DE3418023A1 (de) 1984-11-22
ES532476A0 (es) 1986-09-16
KE3846A (en) 1989-04-07
FI841906A (fi) 1984-11-17
HUT37168A (en) 1985-11-28
DE3418023C2 (fr) 1988-08-18
FI81114C (fi) 1990-09-10
IT8420928A0 (it) 1984-05-15
NZ208013A (en) 1987-07-31
FR2547594A1 (fr) 1984-12-21
HU193928B (en) 1987-12-28
JPH02128693A (ja) 1990-05-17
KR920001366B1 (ko) 1992-02-11
KR840008817A (ko) 1984-12-19
IL71824A (en) 1988-09-30
DK239784A (da) 1984-11-17
IT8420928A1 (it) 1985-11-15
AU2779184A (en) 1984-11-22
JPH0229079B2 (fr) 1990-06-27
SE8402619L (sv) 1984-11-17
IE841200L (en) 1984-11-16
DK163127B (da) 1992-01-20
JPS59232094A (ja) 1984-12-26
YU43846B (en) 1989-12-31
AT393691B (de) 1991-11-25
SU1344249A3 (ru) 1987-10-07
GB8412368D0 (en) 1984-06-20
FI81114B (fi) 1990-05-31
IL71824A0 (en) 1984-09-30
IE57444B1 (en) 1992-09-09
NL8401572A (nl) 1984-12-17
ES8700267A1 (es) 1986-09-16
JPH0555111B2 (fr) 1993-08-16
BE899667A (fr) 1984-11-16
GB2141425B (en) 1986-12-03
ATA160984A (de) 1991-05-15
FR2547594B1 (fr) 1988-03-25
YU84984A (en) 1988-04-30
KR900019562A (ko) 1990-12-24
SE8402619D0 (sv) 1984-05-15
CY1465A (en) 1989-07-21
DK239784D0 (da) 1984-05-15
IT1175498B (it) 1987-07-01
GR81581B (fr) 1984-12-11
ZA843591B (en) 1985-02-27
GB2141425A (en) 1984-12-19
CA1241282A (fr) 1988-08-30
DK163127C (da) 1992-06-09
FI841906A0 (fi) 1984-05-11
PT78590A (en) 1984-06-01
SE460364B (sv) 1989-10-02
LU85362A1 (fr) 1985-03-21

Similar Documents

Publication Publication Date Title
AU576317B2 (en) 2-thiol- or 2-alkylthio- imidazoles, and intermediates
AU564963B2 (en) N-alkoxyaminosulfonyl-ureas and n-alkyl- sulfonylaminosulfonylureas
AU581061B2 (en) Antibiotic clathrates
PH16583A (en) Antibiotic x-14868a,b,c,and d
AU570271B2 (en) Bbm-2478 antibiotic complex
AU557782B2 (en) A47934 antibiotic and production
AU565892B2 (en) C-20-modified macrolide antibiotics
AU565667B2 (en) N, n-di-n-propyl-4-hydroxy-3- methanesulphonamidophenethylamine
AU557104B2 (en) Antibiotic a41030 complex
AU569294B2 (en) Antibiotic bbm-1675a and b, from actinomadura verrucosospora
AU2656284A (en) Conveyer system
AU583840B2 (en) Conveyer systems
AU2966784A (en) Conveyor system
AU2376684A (en) 5-oxo-2,4-dichloro-4-substituted pentanenitriles
AU534728B3 (en) Buffers
AU563648B2 (en) Benzamidines
AU562921B2 (en) Antibiotic m 9026 and associated factors 1, 2 and 3
AU585264B2 (en) Antibiotic A80190
AU558086B2 (en) Variable trim-engagement system
AU1402488A (en) 2-chloro-5-aminothiophenol, and its production
GB8430613D0 (en) Antibiotic
AU536957B2 (en) Antibiotic am-3603
AU563809B2 (en) 3-acyl-2-nitromethylene-tetrahydro-2h-1,3-thiazines
AU573901B2 (en) Conveyor system
AU568385B2 (en) Pyrrolizinones and indolizinones